http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0011849-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da54f7ebbd2d9d8a82f92aca4d1b4e48 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C233-12 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C233-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C237-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-02 |
filingDate | 1979-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6c5b5ea8ea0f7ee56a6e61d1c2168243 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba23c9c14ff6c0e51d92af5cbf593907 |
publicationDate | 1980-06-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0011849-A1 |
titleOfInvention | 2,4,6-Triiodo-isophthalamic acid derivatives, their preparation and X-ray contrast agents based on these compounds |
abstract | The invention relates to compounds of the general formula I <IMAGE> in which R1 represents an optionally substituted alkyl radical, R2, R3 and R4 represent a hydrogen atom or a lower alkyl radical, R5 represents an optionally hydroxy- or methoxy-substituted lower alkyl radical, n the numbers 1, 2 or 3 and Z represents an -A-NHCH3 radical, where A is an amino acid radical which is bonded with its CO group to -NHCH3 and with its NH group to CO, or Z represents a straight-chain or branched lower hydroxyalkylamino- The radical represents when R1 is a monohydroxy- or monoalkoxy-substituted lower alkyl radical and / or R3 is an optionally hydroxyl- or methoxy-substituted lower alkyl radical, and their lower alkyl esters with alkanols, their salts with physiologically compatible bases, a process for the preparation of the compound of general formula I and their use as a shading substance in X-ray contrast media. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9310079-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0049745-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0079397-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9310078-A1 |
priorityDate | 1978-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 88.